Uganda

Reimbursed Care Access

Classical psychedelics (psilocybin, MDMA, DMT, mescaline, ibogaine, 5‑MeO‑DMT, 2C‑series, ayahuasca) are effectively prohibited for general use in Uganda and have no authorised medical reimbursement outside of approved research. Ketamine is widely used and available in Ugandan health facilities as an essential anaesthetic; esketamine (Spravato) has no record of regulatory approval or routine clinical availability in Uganda.